📣 VC round data is live. Check it out!
- Public Comps
- Mani Inc.
Mani Inc. Valuation Multiples
Discover revenue and EBITDA valuation multiples for Mani Inc. and similar public comparables like Curiox Biosystems, Shanghai Haohai, Arcs Co, Conmed and more.
Mani Inc. Overview
About Mani Inc.
Mani Inc manufactures medical devices and dental instruments. It sells products in four categories: surgical instruments, ophthalmic instruments, suture needles, and dental instruments. Mani's surgical products include instruments such as staplers, vessel knives, and bone saws. Its ophthalmic instruments include a range of knives used during eye surgery and ophthalmic sutures. Mani's suture needles business includes a variety of taper point and cutting eyeless needles, which require suture attachment and sterilization by the customer, as well as stainless-steel eyed needles. The firm's dental instruments include endodontic instruments and accessories, root canal equipment, and finishing and polishing instruments.
Founded
1959
HQ

Employees
3.7K
Website
Financials (LTM)
EV
$907M
Valuation Multiples
Start free trialMani Inc. Financials
Mani Inc. reported last 12-month revenue of $205M and EBITDA of $75M.
In the same LTM period, Mani Inc. generated $138M in gross profit, $75M in EBITDA, and $43M in net income.
Revenue (LTM)
Mani Inc. P&L
In the most recent fiscal year, Mani Inc. reported revenue of $196M and EBITDA of $70M.
Mani Inc. is profitable as of last fiscal year, with gross margin of 62%, EBITDA margin of 36%, and net margin of 17%.
Financial data powered by Morningstar, Inc.
Mani Inc. Stock Performance
Mani Inc. has current market cap of $1B, and enterprise value of $907M.
Market Cap Evolution
Mani Inc.'s stock price is $10.66.
Mani Inc. share price decreased by 3.1% in the last 30 days, and increased by 37.1% in the last year.
Mani Inc. has an EPS (earnings per share) of $0.34.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $907M | $1B | -3.1% | -3.1% | 12.5% | 37.1% | $0.34 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMani Inc. Valuation Multiples
Mani Inc. trades at 4.4x EV/Revenue multiple, and 12.2x EV/EBITDA.
EV / Revenue (LTM)
Mani Inc. Financial Valuation Multiples
As of June 3, 2026, Mani Inc. has market cap of $1B and EV of $907M.
Mani Inc. has a P/E ratio of 24.5x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Mani Inc. Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Mani Inc. Margins & Growth Rates
Mani Inc. grew revenue by 6% and EBITDA by 9% in the last fiscal year.
In the most recent fiscal year, Mani Inc. reported gross margin of 62%, EBITDA margin of 36%, and net margin of 17%.
Mani Inc. Margins
Mani Inc. Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Mani Inc. Operational KPIs
Mani Inc.'s revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Mani Inc.'s Rule of 40 is 47% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Mani Inc.'s Rule of X is 62% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Mani Inc. Competitors
Mani Inc. competitors include Curiox Biosystems, Shanghai Haohai, Arcs Co, Conmed, MedicalSystem Technology, ChemoMetec, Artivion, SEEGENE, Medartis and iRadimed.
Most Mani Inc. public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 303.7x | 303.7x | (67.6x) | - | |||
| 2.0x | 2.0x | 10.7x | 9.6x | |||
| 0.2x | 0.2x | 3.7x | 3.8x | |||
| 1.3x | 1.3x | 6.7x | 6.7x | |||
| 21.4x | 19.2x | 72.6x | 83.5x | |||
| 12.2x | 11.9x | 23.3x | 21.7x | |||
| 2.7x | 2.6x | 13.3x | 12.9x | |||
| 1.9x | 1.9x | 7.4x | 7.7x | |||
This data is available for Pro users. Sign up to see all Mani Inc. competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Mani Inc.
| When was Mani Inc. founded? | Mani Inc. was founded in 1959. |
| Where is Mani Inc. headquartered? | Mani Inc. is headquartered in Japan. |
| How many employees does Mani Inc. have? | As of today, Mani Inc. has over 3K employees. |
| Who is the CEO of Mani Inc.? | Mani Inc.'s CEO is Masaya Watanabe. |
| Is Mani Inc. publicly listed? | Yes, Mani Inc. is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Mani Inc.? | Mani Inc. trades under 7730 ticker. |
| When did Mani Inc. go public? | Mani Inc. went public in 2001. |
| Who are competitors of Mani Inc.? | Mani Inc. main competitors include Curiox Biosystems, Shanghai Haohai, Arcs Co, Conmed, MedicalSystem Technology, ChemoMetec, Artivion, SEEGENE, Medartis, iRadimed. |
| What is the current market cap of Mani Inc.? | Mani Inc.'s current market cap is $1B. |
| What is the current revenue of Mani Inc.? | Mani Inc.'s last 12 months revenue is $205M. |
| What is the current revenue growth of Mani Inc.? | Mani Inc. revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of Mani Inc.? | Current revenue multiple of Mani Inc. is 4.4x. |
| What is the current EBITDA of Mani Inc.? | Mani Inc.'s last 12 months EBITDA is $75M. |
| What is Mani Inc.'s EBITDA margin? | Mani Inc.'s last 12 months EBITDA margin is 36%. |
| What is the current EV/EBITDA multiple of Mani Inc.? | Current EBITDA multiple of Mani Inc. is 12.2x. |
| What is the current FCF of Mani Inc.? | Mani Inc.'s last 12 months FCF is $30M. |
| What is Mani Inc.'s FCF margin? | Mani Inc.'s last 12 months FCF margin is 14%. |
| What is the current EV/FCF multiple of Mani Inc.? | Current FCF multiple of Mani Inc. is 30.6x. |
| How many companies Mani Inc. has acquired to date? | Mani Inc. hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Mani Inc. has invested to date? | Mani Inc. hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Mani Inc.
Lists including Mani Inc.
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.